반응식
[NH:1]1[CH2:6][CH2:5][CH:4]([CH2:7][NH:8][C:9]([N:11]2[C:15]3[CH:16]=[CH:17][CH:18]=[CH:19][C:14]=3[N:13]([CH2:20][CH3:21])[C:12]2=[O:22])=[O:10])[CH2:3][CH2:2]1.[CH3:23]O[C:25]1[CH:30]=[CH:29][C:28]([O:31][CH2:32][CH:33]2[O:35][CH2:34]2)=[CH:27][CH:26]=1>>[NH:1]1[CH2:6][CH2:5][CH:4]([CH2:7][NH:8][C:9]([N:11]2[C:15]3[CH:16]=[CH:17][CH:18]=[CH:19][C:14]=3[N:13]([CH:20]([CH3:23])[CH3:21])[C:12]2=[O:22])=[O:10])[CH2:3][CH2:2]1.[O:35]1[CH:33]([CH2:32][O:31][C:28]2[CH:27]=[CH:26][CH:25]=[CH:30][CH:29]=2)[CH2:34]1참가 물질
4
실험 절차
The procedure given in Example 104 was followed using 3-ethyl-2-oxo-2,3-dihydro-benzimidazole-1-carboxylic acid (piperidin-4-ylmethyl)-amide and glycidyl 4-methoxyphenyl ether as a reactant, instead of 3-isopropyl-2-oxo-2,3-dihydro-benzimidazole-1-carboxylic acid (piperidin-4-ylmethyl)-amide and 1,2-epoxy-3-phenoxypropane, to give the title compound.
출처 및 근거
- ORD 기록
- ord-829d1f72d52f4f8a81395b93e97eb7cc
- 출처 데이터셋
- uspto-grants-2014_02
- 특허 번호
- US08642772B2
연결된 노트
불러오는 중…